InductOs (dibotermin alfa) - Important Safety Information from Medtronic BioPharma B.V. as approved by the HPRA

Notice type: 3rd Party Publications

Date: 18/08/2015

 

Problem Or Issue:
Important Safety Information communication from Medtronic BioPharma B.V. on potential drug shortage for InductOs (dibotermin alfa).

Important Safety Information - InductOs (dibotermin alfa)


« Back